Alexander N. Obedin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alexander N. Obedin has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Yuriy Vitalievich Bykov
Federal State Budgetary Educational Institution of Higher Professional Education “Stavropol State Medical University” of the Ministry of Healthcare of the Russian Federation
27 shared publications - Oleg V. Zinchenko
Stavropol State Medical University
18 shared publications - Evgeniy V. Volkov
Stavropol State Medical University
17 shared publications - Ivan V. Yatsuk
Stavropol State Medical University
17 shared publications - Василий Владимирирович Фишер
Stavropol State Medical University, Stavropol, Russia
15 shared publications - Alla A. Muravyeva
Stavropol State Medical University
8 shared publications
Latest Publications
- 16 November 2026
- Published by Arterialnaya Gipertenziya in Translational Medicine
- Vol. 13 (5)
Ferroptosis in the pathogenesis of brain injury and cognitive impairment in children
Background. Brain injury in children is associated with molecular disturbances that may adversely affect the maturation of neural tissue and the development of cognitive functions. Particular attention has been focused on ferroptosis, an iron-dependent form of regulated cell death characterized by disturbances in iron homeostasis, membrane lipid peroxidation, and impairment of antioxidant defense mechanisms. Objective. To summarize current knowledge of the molecular mechanisms of ferroptosis and its potential contribution to the pathogenesis of brain injury and cognitive impairment in children. Materials and Methods. Russian and international scientific publications indexed in PubMed and eLIBRARY.RU were analyzed, primarily covering the period from 2012 to 2026. The review included experimental studies involving cellular models, neonatal animals, and organotypic brain slice preparations, as well as clinical evidence concerning hypoxic-ischemic and traumatic brain injury and neurological complications of critical illness in children. Results. The principal molecular mechanisms underlying ferroptotic injury to neural tissue include the accumulation of labile ferrous iron, enhanced lipid peroxidation, depletion of glutathione-dependent antioxidant defenses, and reduced glutathione peroxidase 4 activity. Mitochondrial dysfunction, disruption of the blood-brain barrier, and inflammatory activation of microglia also contribute to these processes. Experimental studies have demonstrated that ferroptosis inhibition attenuates hypoxic-ischemic brain injury, oligodendrocyte death, and disturbances in myelination. The increased susceptibility of oligodendrocytes and their precursor cells to oxidative injury may be particularly important in the development of delayed neurological impairment. Clinical observations in newborns with hypoxic-ischemic encephalopathy have revealed associations between disturbances in iron metabolism, lipid peroxidation, and adverse neurological outcomes. However, these alterations are not specific indicators of ferroptosis, while evidence regarding its involvement in traumatic and seizure-related brain injury in children remains largely experimental or indirect. Conclusion. Ferroptosis may represent one of the mechanisms contributing to secondary injury in the developing brain, potentially impairing myelination and the maturation of neural networks. Its proposed association with delayed cognitive impairment in children requires further experimental investigation and direct clinical confirmation.
- 16 November 2026
- Published by Arterialnaya Gipertenziya in Translational Medicine
- Vol. 13 (5)
Ferroptosis in the pathogenesis of brain injury and cognitive impairment in children
Background. Brain injury in children is associated with molecular disturbances that may adversely affect the maturation of neural tissue and the development of cognitive functions. Particular attention has been focused on ferroptosis, an iron-dependent form of regulated cell death characterized by disturbances in iron homeostasis, membrane lipid peroxidation, and impairment of antioxidant defense mechanisms. Objective. To summarize current knowledge of the molecular mechanisms of ferroptosis and its potential contribution to the pathogenesis of brain injury and cognitive impairment in children. Materials and Methods. Russian and international scientific publications indexed in PubMed and eLIBRARY.RU were analyzed, primarily covering the period from 2012 to 2026. The review included experimental studies involving cellular models, neonatal animals, and organotypic brain slice preparations, as well as clinical evidence concerning hypoxic-ischemic and traumatic brain injury and neurological complications of critical illness in children. Results. The principal molecular mechanisms underlying ferroptotic injury to neural tissue include the accumulation of labile ferrous iron, enhanced lipid peroxidation, depletion of glutathione-dependent antioxidant defenses, and reduced glutathione peroxidase 4 activity. Mitochondrial dysfunction, disruption of the blood-brain barrier, and inflammatory activation of microglia also contribute to these processes. Experimental studies have demonstrated that ferroptosis inhibition attenuates hypoxic-ischemic brain injury, oligodendrocyte death, and disturbances in myelination. The increased susceptibility of oligodendrocytes and their precursor cells to oxidative injury may be particularly important in the development of delayed neurological impairment. Clinical observations in newborns with hypoxic-ischemic encephalopathy have revealed associations between disturbances in iron metabolism, lipid peroxidation, and adverse neurological outcomes. However, these alterations are not specific indicators of ferroptosis, while evidence regarding its involvement in traumatic and seizure-related brain injury in children remains largely experimental or indirect. Conclusion. Ferroptosis may represent one of the mechanisms contributing to secondary injury in the developing brain, potentially impairing myelination and the maturation of neural networks. Its proposed association with delayed cognitive impairment in children requires further experimental investigation and direct clinical confirmation.
- Open Access
- 30 July 2026
- Published by Chita State Medical Academy in Transbaikalian Medical Bulletin
- No. 2,p. 218-229
NON-IMMUNOGENIC STAPHYLOKINASE IN THE TREATMENT OF INTERMEDIATE–HIGH- RISK PULMONARY EMBOLISM
Intermediate–high-risk pulmonary embolism (PE) is characterized by preserved systemic hemodynamics in the presence of right ventricular (RV) dysfunction and elevated cardiac-specific biomarkers, which are associated with a risk of early clinical deterioration. The appropriateness of systemic thrombolytic therapy (TLT) in this patient population remains controversial, as it requires careful balancing of the potential reperfusion benefits against the risk of hemorrhagic complications. This review summarizes current evidence regarding anticoagulant therapy, systemic and catheter-directed reperfusion strategies, and discusses the potential role of non-immunogenic staphylokinase. As a clinical illustration, we present a case of a patient with intermediate–high-risk PE who demonstrated clinical worsening despite anticoagulant therapy and was treated with systemic TLT using non-immunogenic staphylokinase, resulting in complete thrombus resolution, restoration of RV function, and absence of hemorrhagic complications. These findings highlight the need for further research to refine patient selection criteria and optimize treatment strategies.
- 30 July 2026
- Published by Chita State Medical Academy in Transbaikalian Medical Bulletin
- No. 2,p. 218-229
Open AccessNON-IMMUNOGENIC STAPHYLOKINASE IN THE TREATMENT OF INTERMEDIATE–HIGH- RISK PULMONARY EMBOLISM
Intermediate–high-risk pulmonary embolism (PE) is characterized by preserved systemic hemodynamics in the presence of right ventricular (RV) dysfunction and elevated cardiac-specific biomarkers, which are associated with a risk of early clinical deterioration. The appropriateness of systemic thrombolytic therapy (TLT) in this patient population remains controversial, as it requires careful balancing of the potential reperfusion benefits against the risk of hemorrhagic complications. This review summarizes current evidence regarding anticoagulant therapy, systemic and catheter-directed reperfusion strategies, and discusses the potential role of non-immunogenic staphylokinase. As a clinical illustration, we present a case of a patient with intermediate–high-risk PE who demonstrated clinical worsening despite anticoagulant therapy and was treated with systemic TLT using non-immunogenic staphylokinase, resulting in complete thrombus resolution, restoration of RV function, and absence of hemorrhagic complications. These findings highlight the need for further research to refine patient selection criteria and optimize treatment strategies.
- 1 July 2026
- Published by Media Sphere Publishing Group in Russian Journal of Pain
- Vol. 24 (2)
Analgesic efficacy of ketamine in pediatric practice
Pain syndrome (PS) poses a serious challenge in children and adolescents admitted in ICUs. This review describes the outcomes of analgesic ketamine administration in pediatric patients with various PS. It discusses the advantages and disadvantages of this drug for pain relief in childhood. The mechanisms of analgesic effect through the effect on NMDA and opiate receptors are described. Pharmacokinetics of ketamine is described. The main dosages and routes of administration for PS relief in children and adolescents are indicated. The authors analyze clinical data on ketamine versus other analgesics for relief of intraoperative and postoperative pain, PS associated with cancer and chronic PS. Pediatric anesthesiologists should consider this analgesic for PS relief in children and adolescents.
- 1 July 2026
- Published by Media Sphere Publishing Group in Russian Journal of Pain
- Vol. 24 (2)
Analgesic efficacy of ketamine in pediatric practice
Pain syndrome (PS) poses a serious challenge in children and adolescents admitted in ICUs. This review describes the outcomes of analgesic ketamine administration in pediatric patients with various PS. It discusses the advantages and disadvantages of this drug for pain relief in childhood. The mechanisms of analgesic effect through the effect on NMDA and opiate receptors are described. Pharmacokinetics of ketamine is described. The main dosages and routes of administration for PS relief in children and adolescents are indicated. The authors analyze clinical data on ketamine versus other analgesics for relief of intraoperative and postoperative pain, PS associated with cancer and chronic PS. Pediatric anesthesiologists should consider this analgesic for PS relief in children and adolescents.
- 19 June 2026
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in EMERGENCY MEDICAL CARE
- Vol. 27 (2)
Emergency medical care in the prehospital setting for acute oral poisoning in children
Objective. To review current national and international data on the diagnosis and emergency management of acute oral poisoning in children in the prehospital setting. Materials and Methods. 22 sources were analyzed, including clinical guidelines, original studies, and recent reviews, with a focus on early diagnostic strategies and therapeutic approaches prior to hospital admission. Results. Acute poisonings remain a significant cause of mortality in children, particularly among those under five years of age and adolescents with intentional intoxications. Key priorities in the prehospital phase include history taking, recognition of toxidromes, stabilization of vital functions, gastrointestinal decontamination (gastric lavage, activated charcoal), initiation of infusion therapy, and, when indicated, administration of antidotes. Conclusion. Proficiency in emergency care algorithms for acute pediatric poisonings substantially reduces complications and mortality risk, underscoring the practical relevance of these data for emergency medical service physicians and pediatric anesthesiologists-intensivists.
- 19 June 2026
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in EMERGENCY MEDICAL CARE
- Vol. 27 (2)
Emergency medical care in the prehospital setting for acute oral poisoning in children
Objective. To review current national and international data on the diagnosis and emergency management of acute oral poisoning in children in the prehospital setting. Materials and Methods. 22 sources were analyzed, including clinical guidelines, original studies, and recent reviews, with a focus on early diagnostic strategies and therapeutic approaches prior to hospital admission. Results. Acute poisonings remain a significant cause of mortality in children, particularly among those under five years of age and adolescents with intentional intoxications. Key priorities in the prehospital phase include history taking, recognition of toxidromes, stabilization of vital functions, gastrointestinal decontamination (gastric lavage, activated charcoal), initiation of infusion therapy, and, when indicated, administration of antidotes. Conclusion. Proficiency in emergency care algorithms for acute pediatric poisonings substantially reduces complications and mortality risk, underscoring the practical relevance of these data for emergency medical service physicians and pediatric anesthesiologists-intensivists.
- Open Access
- 19 May 2026
- Published by Chita State Medical Academy in Transbaikalian Medical Bulletin
- No. 1,p. 103-119
Acute respiratory distress syndrome in children as a systemic pathological process
Pediatric acute respiratory distress syndrome (PARDS) remains one of the most complex and clinically significant forms of acute respiratory failure (ARF) in pediatric intensive care. High variability of the clinical course, limited effectiveness of standard respiratory strategies, and unfavorable outcomes in a subset of patients indicate the insufficiency of traditional pathogenetic concepts predominantly based on the alveolar-inflammatory model. This article considers PARDS as a systemic pathological process driven by the sequential involvement of microcirculatory, energetic and regulatory mechanisms. Particular attention is paid to endothelial dysfunction, impaired tissue perfusion, and mitochondrial dysfunction as key factors underlying the development of energy deficiency and the limitation of process reversibility. It is shown that hypoxemia and ARF within this paradigm represent clinical manifestations of a deeper hypoxic-ischemic cascade affecting both the lungs and the central nervous system. The proposed concept has practical significance for improving the understanding of pathogenesis, stratifying disease severity, and assessing prognosis in PARDS.
- 19 May 2026
- Published by Chita State Medical Academy in Transbaikalian Medical Bulletin
- No. 1,p. 103-119
Open AccessAcute respiratory distress syndrome in children as a systemic pathological process
Pediatric acute respiratory distress syndrome (PARDS) remains one of the most complex and clinically significant forms of acute respiratory failure (ARF) in pediatric intensive care. High variability of the clinical course, limited effectiveness of standard respiratory strategies, and unfavorable outcomes in a subset of patients indicate the insufficiency of traditional pathogenetic concepts predominantly based on the alveolar-inflammatory model. This article considers PARDS as a systemic pathological process driven by the sequential involvement of microcirculatory, energetic and regulatory mechanisms. Particular attention is paid to endothelial dysfunction, impaired tissue perfusion, and mitochondrial dysfunction as key factors underlying the development of energy deficiency and the limitation of process reversibility. It is shown that hypoxemia and ARF within this paradigm represent clinical manifestations of a deeper hypoxic-ischemic cascade affecting both the lungs and the central nervous system. The proposed concept has practical significance for improving the understanding of pathogenesis, stratifying disease severity, and assessing prognosis in PARDS.
- Open Access
- 21 April 2026
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 23 (2) , 42-48
Features of the course of neonatal respiratory distress in preterm infants depending on the inflammatory phenotype
Introduction . Respiratory distress (RD) is the most common reason for neonatal hospitalization in the neonatal intensive care unit (NICU).The objective was to identify associations between the inflammatory phenotype associated with neonatal RD in preterm infants and survival and the need for invasive mechanical ventilation. Materials and methods . A prospective, observational, multicenter study conducted from June 1 to September 6, 2025, in the NICUs of four perinatal centers in the Russian Federation (Ufa ( n = 124), Stavropol ( n = 123), Astrakhan ( n = 70), and Khabarovsk ( n = 47), total 364). Inclusion criteria : preterm infants admitted to the NICU with signs of respiratory distress, gestation age 34 weeks or less. The severity of the neonatal condition was assessed using the nSOFA scale, and the invasiveness of hemodynamic support was assessed using the VIS index [7]. The primary endpoint was 28-day mortality. The secondary endpoint was the need for invasive mechanical ventilation. Inflammatory phenotypes were identified during the first 24 hours of admission to the intensive care unit (stage one) and after three days of treatment (stage two) using a logistic regression model. A calculator was used that included six laboratory parameters: leukocytes, platelets, procalcitonin, C-reactive protein, D-dimer, and fibrinogen, followed by ranking in points and weighting coefficients. Based on the total value of the weighting coefficients, three subphenotypes of the RD course were identified: hypoinflammatory, intermediate, and hyperinflammatory (less than 0.8, 0.8-1.2, and more than 1.2, respectively). The obtained data were analyzed using SPSS statistical software (version 26.0). Results . At the first stage, the hypoinflammatory subphenotype of RD was detected in 194 (53.3%) newborns, and a mixed phenotype in 170 (46.7%) newborns. On the third day of treatment in the NICU (stage II), the hypoinflammatory phenotype was verified in 205 (76.5%), the intermediate phenotype in 61 (22.8%), and the hyperinflammatory phenotype in 2 (0.7%) newborns. At both the first and the second stages of the study, the hypoinflammatory phenotype of RD was significantly more common (x 2 = 37.4, p < 0.001). We did not find a statistically significant association between the inflammatory phenotype and mortality (x2 = 1.55, p = 0.214). It was found that patients with an intermediate inflammatory phenotype in RD were significantly more likely to require invasive mechanical ventilation (x2 = 9.786, p = 0.002, AUG ROC 0.678). Conclusion . The severity of the condition and mortality in RD in preterm infants are not associated with inflammatory phenotypes. The presented calculator for assessing the severity of systemic inflammation has moderate discriminatory ability in predicting the need for invasive mechanical ventilation in preterm infants with RD.
- 21 April 2026
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 23 (2) , 42-48
Open AccessFeatures of the course of neonatal respiratory distress in preterm infants depending on the inflammatory phenotype
Introduction . Respiratory distress (RD) is the most common reason for neonatal hospitalization in the neonatal intensive care unit (NICU).The objective was to identify associations between the inflammatory phenotype associated with neonatal RD in preterm infants and survival and the need for invasive mechanical ventilation. Materials and methods . A prospective, observational, multicenter study conducted from June 1 to September 6, 2025, in the NICUs of four perinatal centers in the Russian Federation (Ufa ( n = 124), Stavropol ( n = 123), Astrakhan ( n = 70), and Khabarovsk ( n = 47), total 364). Inclusion criteria : preterm infants admitted to the NICU with signs of respiratory distress, gestation age 34 weeks or less. The severity of the neonatal condition was assessed using the nSOFA scale, and the invasiveness of hemodynamic support was assessed using the VIS index [7]. The primary endpoint was 28-day mortality. The secondary endpoint was the need for invasive mechanical ventilation. Inflammatory phenotypes were identified during the first 24 hours of admission to the intensive care unit (stage one) and after three days of treatment (stage two) using a logistic regression model. A calculator was used that included six laboratory parameters: leukocytes, platelets, procalcitonin, C-reactive protein, D-dimer, and fibrinogen, followed by ranking in points and weighting coefficients. Based on the total value of the weighting coefficients, three subphenotypes of the RD course were identified: hypoinflammatory, intermediate, and hyperinflammatory (less than 0.8, 0.8-1.2, and more than 1.2, respectively). The obtained data were analyzed using SPSS statistical software (version 26.0). Results . At the first stage, the hypoinflammatory subphenotype of RD was detected in 194 (53.3%) newborns, and a mixed phenotype in 170 (46.7%) newborns. On the third day of treatment in the NICU (stage II), the hypoinflammatory phenotype was verified in 205 (76.5%), the intermediate phenotype in 61 (22.8%), and the hyperinflammatory phenotype in 2 (0.7%) newborns. At both the first and the second stages of the study, the hypoinflammatory phenotype of RD was significantly more common (x 2 = 37.4, p < 0.001). We did not find a statistically significant association between the inflammatory phenotype and mortality (x2 = 1.55, p = 0.214). It was found that patients with an intermediate inflammatory phenotype in RD were significantly more likely to require invasive mechanical ventilation (x2 = 9.786, p = 0.002, AUG ROC 0.678). Conclusion . The severity of the condition and mortality in RD in preterm infants are not associated with inflammatory phenotypes. The presented calculator for assessing the severity of systemic inflammation has moderate discriminatory ability in predicting the need for invasive mechanical ventilation in preterm infants with RD.
- Open Access
- 24 March 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 43-52
Surfactant administration and risk of bronchopulmonary dysplasia in preterm infants
Preterm birth is a major public health concern with an estimated 11% of all live births affected globally. There is a rapid increase in the incidence of preterm births in many industrialized countries in the past decade. Pulmonary surfactant is a phospholipid/ protein complex mixture reducing surface tension at the air-liquid interface in the alveoli. Defective surfactant metabolism can worsen the prognosis for infants born prematurely. Extremely preterm infants appear to have a greater risk of respiratory distress syndrome, leading to a longer duration of mechanical ventilation, which, in turn, increases the risk of bronchopulmonary dysplasia. Bronchopulmonary dysplasia remains the most common adverse outcome of preterm birth. Early exogenous-surfactant administration plays a pivotal role in the management of preterm infants with respiratory distress syndrome, reducing morbidity and mortality. This literature review summarizes current knowledge on the physiological effects of pulmonary surfactant, its composition, and various routes of administration. This systematic review describes the most common method of surface-active agent administration – INSURE, thin catheter techniques, surfactant aerosolization, and surfactant administration via laryngeal or supraglottic airway (SALSA). The literature search was conducted using the following keywords: preterm birth, lasting effects of premature birth, pulmonary surfactant, exogenous surfactant, preterm infants, bronchopulmonary dysplasia. A detailed systematic analysis of current domestic and international literature on surfactant use was conducted. A total of 64 scientific publications were selected for analysis. Databases of eLibrary, Scopus, PubMed, and MEDLINE were used.
- 24 March 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 43-52
Open AccessSurfactant administration and risk of bronchopulmonary dysplasia in preterm infants
Preterm birth is a major public health concern with an estimated 11% of all live births affected globally. There is a rapid increase in the incidence of preterm births in many industrialized countries in the past decade. Pulmonary surfactant is a phospholipid/ protein complex mixture reducing surface tension at the air-liquid interface in the alveoli. Defective surfactant metabolism can worsen the prognosis for infants born prematurely. Extremely preterm infants appear to have a greater risk of respiratory distress syndrome, leading to a longer duration of mechanical ventilation, which, in turn, increases the risk of bronchopulmonary dysplasia. Bronchopulmonary dysplasia remains the most common adverse outcome of preterm birth. Early exogenous-surfactant administration plays a pivotal role in the management of preterm infants with respiratory distress syndrome, reducing morbidity and mortality. This literature review summarizes current knowledge on the physiological effects of pulmonary surfactant, its composition, and various routes of administration. This systematic review describes the most common method of surface-active agent administration – INSURE, thin catheter techniques, surfactant aerosolization, and surfactant administration via laryngeal or supraglottic airway (SALSA). The literature search was conducted using the following keywords: preterm birth, lasting effects of premature birth, pulmonary surfactant, exogenous surfactant, preterm infants, bronchopulmonary dysplasia. A detailed systematic analysis of current domestic and international literature on surfactant use was conducted. A total of 64 scientific publications were selected for analysis. Databases of eLibrary, Scopus, PubMed, and MEDLINE were used.
- 19 February 2026
- Published by Chita State Medical Academy in Transbaikalian Medical Bulletin
- No. 4,p. 96-111
PATHOGENETIC MECHANISMS OF HYPOXIC-ISCHEMIC BRAIN INJURY IN CHILDREN AFTER CLINICAL DEATH
Brain death in children after clinical death is one of the most complex and urgent problems of modern pediatric intensive care. Immaturity of the nervous system, high metabolic activity, functional instability of the blood–brain barrier, and incomplete myelination determine the increased vulnerability of the child’s brain to ischemia and hypoxia. This article reviews the main pathogenetic mechanisms: primary (global ischemia, energy deficit, ion imbalance, excitotoxicity), secondary (mitochondrial dysfunction, reperfusion injury, oxidative stress, blood–brain barrier disruption, neuroinflammation), as well as different forms of cell death (apoptosis, necrosis, pathological autophagy). Particular attention is paid to the morphological consequences for the developing brain, including white matter injury, delayed myelination, and loss of neuronal networks. In children, the transition from reversible to irreversible damage occurs faster than in adults, which significantly complicates prognosis and therapeutic interventions. Current understanding of the molecular and morphological mechanisms of brain death has practical significance for improving diagnostics, prognosis, and treatment in pediatric intensive care.
- 19 February 2026
- Published by Chita State Medical Academy in Transbaikalian Medical Bulletin
- No. 4,p. 96-111
PATHOGENETIC MECHANISMS OF HYPOXIC-ISCHEMIC BRAIN INJURY IN CHILDREN AFTER CLINICAL DEATH
Brain death in children after clinical death is one of the most complex and urgent problems of modern pediatric intensive care. Immaturity of the nervous system, high metabolic activity, functional instability of the blood–brain barrier, and incomplete myelination determine the increased vulnerability of the child’s brain to ischemia and hypoxia. This article reviews the main pathogenetic mechanisms: primary (global ischemia, energy deficit, ion imbalance, excitotoxicity), secondary (mitochondrial dysfunction, reperfusion injury, oxidative stress, blood–brain barrier disruption, neuroinflammation), as well as different forms of cell death (apoptosis, necrosis, pathological autophagy). Particular attention is paid to the morphological consequences for the developing brain, including white matter injury, delayed myelination, and loss of neuronal networks. In children, the transition from reversible to irreversible damage occurs faster than in adults, which significantly complicates prognosis and therapeutic interventions. Current understanding of the molecular and morphological mechanisms of brain death has practical significance for improving diagnostics, prognosis, and treatment in pediatric intensive care.
- 19 February 2026
- Published by Chita State Medical Academy in Transbaikalian Medical Bulletin
- No. 4,p. 147-156
COCKAYNE SYNDROME TYPE II
Cockayne syndrome (CS) is a rare autosomal recessive neurodegenerative disorder associated with impaired DNA repair, developmental delay, and multisystem involvement. This article presents a rare clinical case of type II CS in a child with a confirmed ERCC6 gene mutation and a severe disease course. Symptoms manifested in the neonatal period and progressed with profound neurological deficits, sensorineural hearing loss, ophthalmologic disorders, epileptic syndrome, and persistent malnutrition. A distinctive feature of this case is the unusually long survival (up to 17 years), which is exceptional for CS type II, typically associated with a poor prognosis. The diagnosis was confirmed by molecular genetic testing, and neuroimaging revealed characteristic brain abnormalities. The patient received supportive care based on a multidisciplinary approach, including nutritional, symptomatic, antiepileptic, and palliative treatment. The condition remained stably severe and required continuous medical supervision. This case emphasizes the importance of early diagnosis, ongoing multidisciplinary management, and clinical vigilance in children with rare neurodegenerative disorders.
- 19 February 2026
- Published by Chita State Medical Academy in Transbaikalian Medical Bulletin
- No. 4,p. 147-156
COCKAYNE SYNDROME TYPE II
Cockayne syndrome (CS) is a rare autosomal recessive neurodegenerative disorder associated with impaired DNA repair, developmental delay, and multisystem involvement. This article presents a rare clinical case of type II CS in a child with a confirmed ERCC6 gene mutation and a severe disease course. Symptoms manifested in the neonatal period and progressed with profound neurological deficits, sensorineural hearing loss, ophthalmologic disorders, epileptic syndrome, and persistent malnutrition. A distinctive feature of this case is the unusually long survival (up to 17 years), which is exceptional for CS type II, typically associated with a poor prognosis. The diagnosis was confirmed by molecular genetic testing, and neuroimaging revealed characteristic brain abnormalities. The patient received supportive care based on a multidisciplinary approach, including nutritional, symptomatic, antiepileptic, and palliative treatment. The condition remained stably severe and required continuous medical supervision. This case emphasizes the importance of early diagnosis, ongoing multidisciplinary management, and clinical vigilance in children with rare neurodegenerative disorders.
- Open Access
- 20 December 2025
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in EMERGENCY MEDICAL CARE
- Vol. 26 (4) , 91-96
Prehospital management of cardiac arrhythmias in children: emergency care strategies — a review
Objective: to review current national and international literature on the diagnosis and emergency management of pediatric arrhythmias in the prehospital setting. Materials and methods. An analysis of 21 literary sources was conducted, including clinical guidelines, studies, and reviews published in recent years, with a focus on prehospital strategies for managing arrhythmias in children . Results . Cardiac rhythm disturbances in children can be life-threatening, especially in the presence of hemodynamic instability. In the prehospital phase, it is crucial to rapidly perform clinical and instrumental diagnostics, classify the type of arrhythmia, and initiate timely treatment. Effective methods include vagal maneuvers, administration of adenosine, atropine, epinephrine, as well as synchronized cardioversion and defibrillation when indicated. Conclusion . Knowledge of diagnostic and treatment algorithms for pediatric arrhythmias in the prehospital setting significantly improves survival rates and reduces the risk of complications. The findings are of practical relevance for emergency medical service physicians and pediatric intensivists.
- 20 December 2025
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in EMERGENCY MEDICAL CARE
- Vol. 26 (4) , 91-96
Open AccessPrehospital management of cardiac arrhythmias in children: emergency care strategies — a review
Objective: to review current national and international literature on the diagnosis and emergency management of pediatric arrhythmias in the prehospital setting. Materials and methods. An analysis of 21 literary sources was conducted, including clinical guidelines, studies, and reviews published in recent years, with a focus on prehospital strategies for managing arrhythmias in children . Results . Cardiac rhythm disturbances in children can be life-threatening, especially in the presence of hemodynamic instability. In the prehospital phase, it is crucial to rapidly perform clinical and instrumental diagnostics, classify the type of arrhythmia, and initiate timely treatment. Effective methods include vagal maneuvers, administration of adenosine, atropine, epinephrine, as well as synchronized cardioversion and defibrillation when indicated. Conclusion . Knowledge of diagnostic and treatment algorithms for pediatric arrhythmias in the prehospital setting significantly improves survival rates and reduces the risk of complications. The findings are of practical relevance for emergency medical service physicians and pediatric intensivists.